1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts
This gathering brings together leading minds from academia, clinical sites, and research institutions across Central Europe to address shared challenges in rare diseases and advanced therapies. The European Union estimates that between 6,000 and 8,000 rare diseases affect approximately 30 million pe...
Đã lưu trong:
| Định dạng: | Online |
|---|---|
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
Masaryk University Press
2024
|
| Những chủ đề: | |
| Truy cập trực tuyến: | ONIX_20241219_9788028006525_22 |
| Các nhãn: |
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| _version_ | 1869525620458782720 |
|---|---|
| collection | Directory of Open Access Books |
| description | This gathering brings together leading minds from academia, clinical sites, and research institutions across Central Europe to address shared challenges in rare diseases and advanced therapies. The European Union estimates that between 6,000 and 8,000 rare diseases affect approximately 30 million people across the region, representing around 6-8% of the population. These conditions are often chronic, progressive, and life-threatening, significantly impacting patients' quality of life. On a local level, over half a million people in the Czech R. alone are affected by rare diseases. Despite these numbers, many patients are still waiting for an accurate diagnosis. The number of newly identified rare diseases continues to rise, alongside well-known challenges such as delays in diagnosis. The leading experts in Advanced Therapy Medicinal Products (ATMPs) from the European Union (EU) are significantly contributing to research across the entire ATMP life-cycle. These contributions span multiple stages, from initial discovery and development to clinical trials, manufacturing, regulation, and post-market surveillance. Their research addresses key challenges in the field, such as improving the efficacy, safety, and scalability of gene therapies, cell therapies, and tissue-engineered products. |
| format | Online |
| id | doab-20.500.12854ir-148527 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | Masaryk University Press |
| publisherStr | Masaryk University Press |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1485272024-12-19T16:45:06Z 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts Salačová, Markéta Pospíšilová, Lucie Vladíková, Hana CREATIC ATMP rare diseases innovative therapies thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders This gathering brings together leading minds from academia, clinical sites, and research institutions across Central Europe to address shared challenges in rare diseases and advanced therapies. The European Union estimates that between 6,000 and 8,000 rare diseases affect approximately 30 million people across the region, representing around 6-8% of the population. These conditions are often chronic, progressive, and life-threatening, significantly impacting patients' quality of life. On a local level, over half a million people in the Czech R. alone are affected by rare diseases. Despite these numbers, many patients are still waiting for an accurate diagnosis. The number of newly identified rare diseases continues to rise, alongside well-known challenges such as delays in diagnosis. The leading experts in Advanced Therapy Medicinal Products (ATMPs) from the European Union (EU) are significantly contributing to research across the entire ATMP life-cycle. These contributions span multiple stages, from initial discovery and development to clinical trials, manufacturing, regulation, and post-market surveillance. Their research addresses key challenges in the field, such as improving the efficacy, safety, and scalability of gene therapies, cell therapies, and tissue-engineered products. 2024-12-19T16:45:05Z 2024-12-19T16:45:05Z 2024 book ONIX_20241219_9788028006525_22 9788028006525 https://directory.doabooks.org/handle/20.500.12854/148527 eng image/jpeg Attribution-NonCommercial-NoDerivatives 4.0 International https://munispace.muni.cz/library/catalog/download/2392/7500/5319-1 Masaryk University Press Masaryk University 82b3cf0f-24e2-456e-bac8-74f7c6371e02 9788028006525 Masaryk University 68 open access |
| spellingShingle | CREATIC ATMP rare diseases innovative therapies thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts |
| title | 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts |
| title_full | 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts |
| title_fullStr | 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts |
| title_full_unstemmed | 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts |
| title_short | 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts |
| title_sort | 1st central european conference for advanced therapy and immunotherapy book of abstracts |
| topic | CREATIC ATMP rare diseases innovative therapies thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders |
| topic_facet | CREATIC ATMP rare diseases innovative therapies thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders |
| url | ONIX_20241219_9788028006525_22 |